Investigating volumetric repainting to mitigate interplay effect on 4D robustly optimized lung cancer plans in pencil beam scanning proton therapy
被引:19
|
作者:
Rana, Suresh
论文数: 0引用数: 0
h-index: 0
机构:
Oklahoma Proton Ctr, Dept Med Phys, Oklahoma City, OK 73142 USA
Baptist Hlth South Florida, Dept Radiat Oncol, Miami Canc Inst, Miami, FL 33139 USA
Florida Int Univ, Herbert Wertheim Coll Med, Dept Radiat Oncol, Miami, FL 33199 USA
Univ Wollongong, Ctr Med Radiat Phys CMRP, Wollongong, NSW, AustraliaOklahoma Proton Ctr, Dept Med Phys, Oklahoma City, OK 73142 USA
Rana, Suresh
[1
,2
,3
,4
]
Rosenfeld, Anatoly B.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Wollongong, Ctr Med Radiat Phys CMRP, Wollongong, NSW, AustraliaOklahoma Proton Ctr, Dept Med Phys, Oklahoma City, OK 73142 USA
Rosenfeld, Anatoly B.
[4
]
机构:
[1] Oklahoma Proton Ctr, Dept Med Phys, Oklahoma City, OK 73142 USA
[2] Baptist Hlth South Florida, Dept Radiat Oncol, Miami Canc Inst, Miami, FL 33139 USA
[3] Florida Int Univ, Herbert Wertheim Coll Med, Dept Radiat Oncol, Miami, FL 33199 USA
[4] Univ Wollongong, Ctr Med Radiat Phys CMRP, Wollongong, NSW, Australia
来源:
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS
|
2021年
/
22卷
/
03期
Purpose The interplay effect between dynamic pencil proton beams and motion of the lung tumor presents a challenge in treating lung cancer patients in pencil beam scanning (PBS) proton therapy. The main purpose of the current study was to investigate the interplay effect on the volumetric repainting lung plans with beam delivery in alternating order ("down" and "up" directions), and explore the number of volumetric repaintings needed to achieve acceptable lung cancer PBS proton plan. Method The current retrospective study included ten lung cancer patients. The total dose prescription to the clinical target volume (CTV) was 70 Gy(RBE) with a fractional dose of 2 Gy(RBE). All treatment plans were robustly optimized on all ten phases in the 4DCT data set. The Monte Carlo algorithm was used for the 4D robust optimization, as well as for the final dose calculation. The interplay effect was evaluated for both the nominal (i.e., without repainting) as well as volumetric repainting plans. The interplay evaluation was carried out for each of the ten different phases as the starting phases. Several dosimetric metrics were included to evaluate the worst-case scenario (WCS) and bandwidth based on the results obtained from treatment delivery starting in ten different breathing phases. Results The number of repaintings needed to meet the criteria 1 (CR1) of target coverage (D-95% >= 98% and D-99% >= 97%) ranged from 2 to 10. The number of repaintings needed to meet the CR1 of maximum dose (Delta D-1% < 1.5%) ranged from 2 to 7. Similarly, the number of repaintings needed to meet CR1 of homogeneity index (Delta HI < 0.03) ranged from 3 to 10. For the target coverage region, the number of repaintings needed to meet CR1 of bandwidth (<100 cGy) ranged from 3 to 10, whereas for the high-dose region, the number of repaintings needed to meet CR1 of bandwidth (<100 cGy) ranged from 1 to 7. Based on the overall plan evaluation criteria proposed in the current study, acceptable plans were achieved for nine patients, whereas one patient had acceptable plan with a minor deviation. Conclusion The number of repaintings required to mitigate the interplay effect in PBS lung cancer (tumor motion < 15 mm) was found to be highly patient dependent. For the volumetric repainting with an alternating order, a patient-specific interplay evaluation strategy must be adopted. Determining the optimal number of repaintings based on the bandwidth and WCS approach could mitigate the interplay effect in PBS lung cancer treatment.
机构:
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul 06351, South KoreaSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul 06351, South Korea
Lee, Woojin
Park, Byoungsuk
论文数: 0引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul 06351, South KoreaSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul 06351, South Korea
Park, Byoungsuk
Pyo, Hongryull
论文数: 0引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul 06351, South KoreaSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul 06351, South Korea
机构:
Mayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
Univ Miami, Dept Radiat Oncol, Miami, FL USAMayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
Yang, Yunze
Gergelis, Kimberly R.
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin, Dept Radiat Oncol, 200 1st St SW, Rochester, MN 55905 USA
Univ Rochester, Dept Radiat Oncol, Sch Med & Dent, Rochester, NY USAMayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
Gergelis, Kimberly R.
Shen, Jiajian
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin, Dept Radiat Oncol, Phoenix, AZ USAMayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
Shen, Jiajian
Afzal, Arslan
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin, Dept Radiat Oncol, 200 1st St SW, Rochester, MN 55905 USAMayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
Afzal, Arslan
Mullikin, Trey C.
论文数: 0引用数: 0
h-index: 0
机构:
Duke Canc Inst, Dept Radiat Oncol, Durham, NC USAMayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
Mullikin, Trey C.
Gao, Robert W.
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin, Dept Radiat Oncol, 200 1st St SW, Rochester, MN 55905 USAMayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
Gao, Robert W.
Aziz, Khaled
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin, Dept Radiat Oncol, 200 1st St SW, Rochester, MN 55905 USAMayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
Aziz, Khaled
Shumway, Dean A.
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin, Dept Radiat Oncol, 200 1st St SW, Rochester, MN 55905 USAMayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
Shumway, Dean A.
Corbin, Kimberly S.
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin, Dept Radiat Oncol, 200 1st St SW, Rochester, MN 55905 USAMayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
Corbin, Kimberly S.
Liu, Wei
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin, Dept Radiat Oncol, Phoenix, AZ USAMayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
Liu, Wei
Mutter, Robert W.
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin, Dept Radiat Oncol, 200 1st St SW, Rochester, MN 55905 USA
Mayo Clin, Dept Pharmacol, Rochester, SA, AustraliaMayo Clin, Dept Radiat Oncol, Phoenix, AZ USA